International Design Registration for Sutrips completed
●Innovasjon Norge approves grants for commercialization phase 2. ●Vekst i Grenland grants development loan to MUB Medical Solutions to strengthen the organization in its efforts to complete final stages of Sutrips development. ●Registration of MUB Medical logo completes in Norway.
●Trademark registration for Suterix completes in Norway. Suterix is a single-use and practical suture kit that doesn’t require sterilization, eliminates the risk of contamination and nosocomial infections
●Grants approved from Norsk Katapult to initiate cooperation with Norner. Norner is a global market leader of industrial R&D services in polymers. ●Trademark registration of Insulanz completes in Norway. Insulanz is a diabetes care kit to assist people in managing their good health.
●Trademark registration of Sutrips completes in India
●Trademark registration of Sutrips completes in USA
●Trademark registration of Sutrips completes in China
●Trademark registration of Sutrips completes in the United Kingdom
●MUB Medical joins Proventia Incubator program. Proventia helps to commercialize business ideas that generate growth in the region. Business ideas should have at least national and preferably international growth potential.
●Trademark registration for Sutrips completes in the EU, Norway and Japan
●Funding approved by Stiftelsen Geneticum and Proventia issues grant for MUB Medical.
●Development loan approved by Klosterøya Fondet. ●MUB Medical joins Proventia preincubation program. Incubation is a well-established method for developing and realizing new business ideas. If, after preincubation, MUB Medical and Proventia still believe that the possibility of success with realization is great, MUB Medical will be offered to enter the incubation program itself.
●Funding approved by Innovasjon Norge to initiate commercialization phase for Sutrips.
●MUB Medical Solutions AS established in Skien, Norway